rs2228149

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000417.3(IL2RA):​c.516C>T​(p.His172His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0444 in 1,613,992 control chromosomes in the GnomAD database, including 2,904 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 354 hom., cov: 31)
Exomes 𝑓: 0.043 ( 2550 hom. )

Consequence

IL2RA
NM_000417.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -0.651

Publications

21 publications found
Variant links:
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Gene-Disease associations (from GenCC):
  • immunodeficiency due to CD25 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • type 1 diabetes mellitus 10
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 10-6021545-G-A is Benign according to our data. Variant chr10-6021545-G-A is described in ClinVar as Benign. ClinVar VariationId is 300256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.651 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.145 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000417.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
NM_000417.3
MANE Select
c.516C>Tp.His172His
synonymous
Exon 4 of 8NP_000408.1P01589
IL2RA
NM_001308242.2
c.368-1604C>T
intron
N/ANP_001295171.1Q5W005
IL2RA
NM_001308243.2
c.368-2046C>T
intron
N/ANP_001295172.1H0Y5Z0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
ENST00000379959.8
TSL:1 MANE Select
c.516C>Tp.His172His
synonymous
Exon 4 of 8ENSP00000369293.3P01589
IL2RA
ENST00000379954.5
TSL:1
c.368-1604C>T
intron
N/AENSP00000369287.1Q5W005
IL2RA
ENST00000447847.2
TSL:1
c.368-2046C>T
intron
N/AENSP00000402024.2H0Y5Z0

Frequencies

GnomAD3 genomes
AF:
0.0548
AC:
8324
AN:
152030
Hom.:
348
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0500
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.0351
Gnomad EAS
AF:
0.0507
Gnomad SAS
AF:
0.0166
Gnomad FIN
AF:
0.0795
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0366
Gnomad OTH
AF:
0.0617
GnomAD2 exomes
AF:
0.0697
AC:
17528
AN:
251486
AF XY:
0.0615
show subpopulations
Gnomad AFR exome
AF:
0.0488
Gnomad AMR exome
AF:
0.248
Gnomad ASJ exome
AF:
0.0353
Gnomad EAS exome
AF:
0.0507
Gnomad FIN exome
AF:
0.0792
Gnomad NFE exome
AF:
0.0370
Gnomad OTH exome
AF:
0.0671
GnomAD4 exome
AF:
0.0434
AC:
63379
AN:
1461844
Hom.:
2550
Cov.:
35
AF XY:
0.0420
AC XY:
30550
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.0483
AC:
1618
AN:
33480
American (AMR)
AF:
0.237
AC:
10612
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0358
AC:
936
AN:
26134
East Asian (EAS)
AF:
0.0647
AC:
2567
AN:
39694
South Asian (SAS)
AF:
0.0172
AC:
1480
AN:
86258
European-Finnish (FIN)
AF:
0.0743
AC:
3967
AN:
53418
Middle Eastern (MID)
AF:
0.0688
AC:
397
AN:
5768
European-Non Finnish (NFE)
AF:
0.0351
AC:
39058
AN:
1111974
Other (OTH)
AF:
0.0454
AC:
2744
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3463
6926
10388
13851
17314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1588
3176
4764
6352
7940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0548
AC:
8334
AN:
152148
Hom.:
354
Cov.:
31
AF XY:
0.0575
AC XY:
4274
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0498
AC:
2068
AN:
41512
American (AMR)
AF:
0.150
AC:
2299
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0351
AC:
122
AN:
3472
East Asian (EAS)
AF:
0.0510
AC:
264
AN:
5172
South Asian (SAS)
AF:
0.0168
AC:
81
AN:
4812
European-Finnish (FIN)
AF:
0.0795
AC:
841
AN:
10580
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0366
AC:
2491
AN:
68000
Other (OTH)
AF:
0.0605
AC:
128
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
375
751
1126
1502
1877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0451
Hom.:
585
Bravo
AF:
0.0658
Asia WGS
AF:
0.0340
AC:
118
AN:
3478
EpiCase
AF:
0.0399
EpiControl
AF:
0.0425

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Immunodeficiency due to CD25 deficiency (2)
-
-
1
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.49
DANN
Benign
0.57
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228149; hg19: chr10-6063508; API